One-Year Mortality, Stroke, And Myocardial Infarction Rates Remain High In The Elderly Despite Beta-Blockade Plus Angiotensin-Converting-Enzyme Inhibition, Angiotensin Receptor Blockade, Or Both: The Valiant Trial